You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
30 June 2015
Zealand announces total number of shares and voting rights in the company as of 30 June 2015
26 June 2015
Phase I trial results for Zealand’s glucagon analogue, ZP4207 support its further development as a ready-to-use rescue treatment for severe hypoglycemia in diabetes patients on insulin therapy
23 June 2015
Major shareholder announcement
22 June 2015
Zealand announces an amendment to its Articles of Association to reflect an increase in share capital after exercise of employee warrants
20 June 2015
Zealand increases its share capital after exercise of employee warrants
12 June 2015